Joanna M Biernacka1, Sun Ju Chung2, Sebastian M Armasu3, Kari S Anderson3, Christina M Lill4, Lars Bertram5, J E Ahlskog6, Laura Brighina7, Roberta Frigerio8, Demetrius M Maraganore9. 1. Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. 2. Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. 3. Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. 4. Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany. 5. Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany; School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology, and Medicine, London, UK. 6. Department of Neurology, Mayo Clinic, Rochester, MN, USA. 7. Department of Neurology, San Gerardo Hospital, Milan Center for Neuroscience, Monza, Italy. 8. Department of Neurology, NorthShore University HealthSystem, Evanston, IL, USA. 9. Department of Neurology, NorthShore University HealthSystem, Evanston, IL, USA. Electronic address: dmaraganore@northshore.org.
Abstract
INTRODUCTION: Genetic factors and environmental exposures, including pesticides, contribute to the risk of Parkinson's disease (PD). There have been few studies of gene and pesticide exposure interactions in PD, and all of the prior studies used a candidate gene approach. METHODS: We performed the first genome-wide gene-environment interaction analysis of pesticide exposure and risk of Parkinson's disease. Analyses were performed using data on >700,000 single nucleotide polymorphisms (SNPs) in 364 discordant sibling pairs. In addition to testing for SNP-pesticide interaction effects, we also performed exploratory analyses of gene-pesticide interactions at the gene level. RESULTS: None of the gene-environment interaction results were significant after genome-wide correction for multiple testing (α = 1.5E-07 for SNP-level tests; α = 2.1E-06 for gene-level tests). Top results in the SNP-level tests provided suggestive evidence (P < 5.0E-06) that the effect of pesticide exposure on PD risk may be modified by SNPs in the ERCC6L2 gene (P = 2.4E-06), which was also supported by suggestive evidence in the gene-level analysis (P = 4.7E-05). None of the candidate genes assessed in prior studies of gene-pesticide interactions reached statistical support in this genome-wide screen. CONCLUSION: Although no significant interactions were identified, several of the genes with suggestive evidence of gene-environment interaction effects have biological plausibility for PD risk. Further investigation of the role of those genes in PD risk, particularly in the context of pesticide exposure, in large and carefully recruited samples is warranted.
INTRODUCTION: Genetic factors and environmental exposures, including pesticides, contribute to the risk of Parkinson's disease (PD). There have been few studies of gene and pesticide exposure interactions in PD, and all of the prior studies used a candidate gene approach. METHODS: We performed the first genome-wide gene-environment interaction analysis of pesticide exposure and risk of Parkinson's disease. Analyses were performed using data on >700,000 single nucleotide polymorphisms (SNPs) in 364 discordant sibling pairs. In addition to testing for SNP-pesticide interaction effects, we also performed exploratory analyses of gene-pesticide interactions at the gene level. RESULTS: None of the gene-environment interaction results were significant after genome-wide correction for multiple testing (α = 1.5E-07 for SNP-level tests; α = 2.1E-06 for gene-level tests). Top results in the SNP-level tests provided suggestive evidence (P < 5.0E-06) that the effect of pesticide exposure on PD risk may be modified by SNPs in the ERCC6L2 gene (P = 2.4E-06), which was also supported by suggestive evidence in the gene-level analysis (P = 4.7E-05). None of the candidate genes assessed in prior studies of gene-pesticide interactions reached statistical support in this genome-wide screen. CONCLUSION: Although no significant interactions were identified, several of the genes with suggestive evidence of gene-environment interaction effects have biological plausibility for PD risk. Further investigation of the role of those genes in PD risk, particularly in the context of pesticide exposure, in large and carefully recruited samples is warranted.
Authors: Alberto Ascherio; Honglei Chen; Marc G Weisskopf; Eilis O'Reilly; Marjorie L McCullough; Eugenia E Calle; Michael A Schwarzschild; Michael J Thun Journal: Ann Neurol Date: 2006-08 Impact factor: 10.422
Authors: L Brighina; R Frigerio; N K Schneider; T G Lesnick; M de Andrade; J M Cunningham; M J Farrer; S J Lincoln; H Checkoway; W A Rocca; D M Maraganore Journal: Neurology Date: 2008-03-05 Impact factor: 9.910
Authors: Todd B Sherer; Jason R Richardson; Claudia M Testa; Byoung Boo Seo; Alexander V Panov; Takao Yagi; Akemi Matsuno-Yagi; Gary W Miller; J Timothy Greenamyre Journal: J Neurochem Date: 2007-01-04 Impact factor: 5.372
Authors: Mike A Nalls; Nathan Pankratz; Christina M Lill; Chuong B Do; Dena G Hernandez; Mohamad Saad; Anita L DeStefano; Eleanna Kara; Jose Bras; Manu Sharma; Claudia Schulte; Margaux F Keller; Sampath Arepalli; Christopher Letson; Connor Edsall; Hreinn Stefansson; Xinmin Liu; Hannah Pliner; Joseph H Lee; Rong Cheng; M Arfan Ikram; John P A Ioannidis; Georgios M Hadjigeorgiou; Joshua C Bis; Maria Martinez; Joel S Perlmutter; Alison Goate; Karen Marder; Brian Fiske; Margaret Sutherland; Georgia Xiromerisiou; Richard H Myers; Lorraine N Clark; Kari Stefansson; John A Hardy; Peter Heutink; Honglei Chen; Nicholas W Wood; Henry Houlden; Haydeh Payami; Alexis Brice; William K Scott; Thomas Gasser; Lars Bertram; Nicholas Eriksson; Tatiana Foroud; Andrew B Singleton Journal: Nat Genet Date: 2014-07-27 Impact factor: 38.330
Authors: Zachary D Wallen; Mary Appah; Marissa N Dean; Cheryl L Sesler; Stewart A Factor; Eric Molho; Cyrus P Zabetian; David G Standaert; Haydeh Payami Journal: NPJ Parkinsons Dis Date: 2020-06-12
Authors: Zachary D Wallen; Mary Appah; Marissa N Dean; Cheryl L Sesler; Stewart A Factor; Eric Molho; Cyrus P Zabetian; David G Standaert; Haydeh Payami Journal: NPJ Parkinsons Dis Date: 2020-06-12
Authors: Thomas W Rösler; Mohamed Salama; Ali S Shalash; Eman M Khedr; Abdelhalim El-Tantawy; Gharib Fawi; Amal El-Motayam; Ehab El-Seidy; Mohamed El-Sherif; Mohamed El-Gamal; Mohamed Moharram; Mohammad El-Kattan; Muhammad Abdel-Naby; Samia Ashour; Ulrich Müller; Astrid Dempfle; Gregor Kuhlenbäumer; Günter U Höglinger Journal: Sci Rep Date: 2018-11-08 Impact factor: 4.379
Authors: Benjamin Meir Jacobs; Daniel Belete; Jonathan Bestwick; Cornelis Blauwendraat; Sara Bandres-Ciga; Karl Heilbron; Ruth Dobson; Mike A Nalls; Andrew Singleton; John Hardy; Gavin Giovannoni; Andrew John Lees; Anette-Eleonore Schrag; Alastair J Noyce Journal: J Neurol Neurosurg Psychiatry Date: 2020-10 Impact factor: 10.154